Tanshinone IIA and Apigenin as potential and natural inhibitors of the metastatic activities of uveal melanoma cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Lübeck, Universität zu Lübeck, Dissertation, 2018
- Keyword
-
Melanoma
Cells
Rho-associated protein kinases
Metastasis
Tumors
- Event
-
Veröffentlichung
- (where)
-
Lübeck
- (who)
-
Zentrale Hochschulbibliothek Lübeck
- (when)
-
2019
- Creator
-
Zuo, Huaxin
- URN
-
urn:nbn:de:gbv:841-20181101477
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zuo, Huaxin
- Zentrale Hochschulbibliothek Lübeck
Time of origin
- 2019
Other Objects (12)
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Pre-metastatic and immunological conditioning of the hepatic niche during melanoma progression
Myeloid-derived suppressor cell (MDSC) recruitment and function in primary and metastatic melanoma lesions
Cannabinoids reduce melanoma cell viability and do not interfere with commonly used targeted therapy in metastatic melanoma in vivo and in vitro
Tumor cell intrinsic Toll-like receptor 4 signaling promotes melanoma progression and metastatic dissemination
Clinical determinants of long-term survival in metastatic uveal melanoma
The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells
The influence of nuclear nodal points on targeted and cytostatic treatment response of metastatic melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Pre-metastatic and immunological conditioning of the hepatic niche during melanoma progression
Myeloid-derived suppressor cell (MDSC) recruitment and function in primary and metastatic melanoma lesions
Cannabinoids reduce melanoma cell viability and do not interfere with commonly used targeted therapy in metastatic melanoma in vivo and in vitro
Tumor cell intrinsic Toll-like receptor 4 signaling promotes melanoma progression and metastatic dissemination
Clinical determinants of long-term survival in metastatic uveal melanoma
The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells
The influence of nuclear nodal points on targeted and cytostatic treatment response of metastatic melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Pre-metastatic and immunological conditioning of the hepatic niche during melanoma progression
Myeloid-derived suppressor cell (MDSC) recruitment and function in primary and metastatic melanoma lesions
Cannabinoids reduce melanoma cell viability and do not interfere with commonly used targeted therapy in metastatic melanoma in vivo and in vitro
Tumor cell intrinsic Toll-like receptor 4 signaling promotes melanoma progression and metastatic dissemination
Clinical determinants of long-term survival in metastatic uveal melanoma
The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells
The influence of nuclear nodal points on targeted and cytostatic treatment response of metastatic melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma